Insider Selling: Merge Healthcare CFO Sells 24,323 Shares of Stock (MRGE)
Merge Healthcare (NASDAQ:MRGE) CFO Steven M. Oreskovich sold 24,323 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $2.09, for a total transaction of $50,835.07. Following the completion of the sale, the chief financial officer now directly owns 175,000 shares in the company, valued at approximately $365,750. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of Merge Healthcare (NASDAQ:MRGE) traded down 0.48% on Wednesday, hitting $2.08. 417,703 shares of the company’s stock traded hands. Merge Healthcare has a 1-year low of $1.97 and a 1-year high of $4.71. The stock’s 50-day moving average is $2.31 and its 200-day moving average is $2.34. The company’s market cap is $197.0 million.
Merge Healthcare (NASDAQ:MRGE) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $0.04 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.04. The company had revenue of $50.90 million for the quarter, compared to the consensus estimate of $52.49 million. During the same quarter last year, the company posted ($0.01) earnings per share. Merge Healthcare’s revenue was down 20.0% compared to the same quarter last year. On average, analysts predict that Merge Healthcare will post $0.10 earnings per share for the current fiscal year.
Separately, analysts at Zacks downgraded shares of Merge Healthcare from a “neutral” rating to an “underperform” rating in a research note on Monday, March 24th. They now have a $2.25 price target on the stock.
Merge Healthcare Incorporated (NASDAQ:MRGE) develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.